Genome Industry SIG
The Genome Industry Special Interest Group (SIG) of Healthtech Finland is a community of Finnish health tech companies that aims to accelerate the production and application of genomic data and genetic tests in health care and for people's wellbeing overall.
In doing so, one of the key objectives of the Genome Industry SIG is to support the inclusion of the technologies and service solutions, developed by the genome industry companies, in the public service solutions in Finland. Successful collaboration with the Finnish public sector will also serve as a strong reference for the companies in their international operations.
The member community of the Genome Industry SIG represents all the major genome industry areas.
As for the genetic tests, there are roughly two types: first, medical genetic tests used by professionals in health care, and, second, tests available for consumers. Most of the genetic tests, even the medical ones, fall into the category of consumer products, as they are available at pharmacies and online stores. Genetic tests require bioinformatics, which enable the processing and combination of the produced genetic data. This is a process that enables interpreting the results of the genetic tests.
The health care sector in Finland needs more professionals that have the knowledge of interpreting genetic data. There is a significant need for education and trainings in this field in Finland.
The member community of the Genome Industry SIG covers all these areas.
Members specialising in medical genetic tests in health care:
Abomics – Genomic Medicine Expertise
Right medication, right patient, right time. It is widely known that a lot of patient's response to drugs vary due to individual genetic differences. Leveraging the genetic information makes personalized medicine a reality. Measurement of a drug effect, a pharmacogenetic test helps finding the right medication with a right dosage – making medication significantly safer and more efficient. With this test adverse drug reactions and complications can be avoided, as well as remarkable cost savings achieved. The results of a pharmacogenetic test do not expire, making it a one-time investment in safer medication for life. Find out more about a pharmacogenetic test. It should also be emphasized that a pharmacogenetic test looks only into the personal attributes in metabolism of drugs and does not look into the risk factors of hereditary disease.
Modulight designs and manufactures lasers and develops applications that can be used in gene sequencing and optogenetics. Living cells can be genetically modified to express light-sensitive ion channels. This enables the use of laser light to control cells in living tissue. Modulight lasers are used in many cell research laboratories worldwide to study photodynamic therapy (PDT). PDT utilizes photosensitizers that can be activated with specifically designed light sources. PDT is at the verge of bringing another revolutionizing tool to be used in management of glioblastoma, uveal melanoma, bile duct, pancreatic and many other cancers.
BC Platforms provides powerful genomic data management solutions to address some of the biggest healthcare challenges by leveraging the convergence of genomics and IT. Our high-performing data management platform enables flexible data integration, secure analysis and interpretation of molecular information and clinical big data in a systematic and standardized manner.
Genevia Technologies is a company providing analysis services for next-generation sequencing data, bioinformatics consulting, and custom bioinformatics software development.
MediSapiens is a leading Finnish Bio-IT company with extensive knowledge in biomedical science. We create need-driven Bio-IT solutions that allow powerful integration of biomedical data combined with intelligent tools to access the data and turn it into actionable knowledge. MediSapiens provides innovative Bio-IT solutions for turning genomic, biomedical and clinical data into scientific, medical, ethical and business value, while empowering health, research and new innovations.
DiagFactor - Personalized Health and Wellbeing through Genomic Information
DiagFactor is the first Finnish digital Genome Health House - one service stop company - that provides DNA tests, genetic counselling, genetic interpretation, corporate wellness and medical education for consumers, corporations, biobanks, local pharma companies and healthcare professionals in the private sector. Today, we are among the forerunner companies in building direct to consumers (DTC) genomics driven wellness; we provide personalized health & wellness platform; and consumer DNA tests and genetic counselling communication via online chatting and video calls. Thus, we help our customers - corporate employees and consumers - to understand and transform their genomic data into informed, better wellbeing and health decisions. Supportive corporate wellness days, MentalFactor wellbeing programs and online tools help people carry out micro changes in their daily life, and thereby empower daily mental wellbeing, recovery, nutrition and fitness.
Euformatics is a biomedical software company that specialises in bioinformatics tools for genome data quality management, variant interpretation and test validation. Euformatics helps medical doctors and molecular genetics laboratories with providing better precision medicine for cancer, common or rare disease diagnostics, through training and easy adoption of NGS technologies. The company's customers are clinical diagnostic laboratories located across the globe.
Pharmaceutical Information Centre
The Pharmaceutical Information Centre (Lääketietokeskus Oy) provides drug information, training and business intelligence services for healthcare and pharmaceutical industry. Company is known of Pharmaca Fennica® drug data database that includes also pharmacogenomic decision support for the benefit of healthcare professionals and patients.